Cote d'Ivoire vs Niger: Treatment coverage for schistosomiasis
Cote d'Ivoire
27.2%
in 2024
Niger
35.1%
in 2024
Cote d'Ivoire rank
38th
Niger rank
36th
Treatment coverage for schistosomiasis over time
- Cote d'Ivoire
- Niger
How they compare
Niger currently reports 35.1% against 27.2% in Cote d'Ivoire, a difference of 7.9%.
That makes Niger's figure about 1.3 times Cote d'Ivoire's.
The two have swapped places 4 times across 13 shared years of data; in 2009 it was Niger ahead.
Cote d'Ivoire ranks 38th and Niger ranks 36th of 45 countries.
Across the 3 decades both report, Cote d'Ivoire averaged higher in 1 and Niger in 2.
Head to head by decade
| Decade | Cote d'Ivoire | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 12.4% | 12.3% | Niger |
| 2010s | 35.7% | 80.8% | 45.1% | Niger |
| 2020s | 49.4% | 45.0% | 4.4% | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Cote d'Ivoire or Niger?
- Niger, at 35.1% against 27.2% in Cote d'Ivoire as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Cote d'Ivoire and Niger?
- 7.9%, with Niger ahead.
- How many years of comparable data are there for Cote d'Ivoire and Niger?
- 13 years are reported by both, from 2009 to 2024.
- How do Cote d'Ivoire and Niger rank globally for treatment coverage for schistosomiasis?
- Cote d'Ivoire ranks 38th and Niger ranks 36th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.